Biofrontera (BFRI) Institutional Ownership $0.72 +0.02 (+2.86%) As of 10:31 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Biofrontera (NASDAQ:BFRI)CurrentInstitutional OwnershipPercentage10.08%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$1.08MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$27.25K Get BFRI Insider Trade Alerts Want to know when executives and insiders are buying or selling Biofrontera stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BFRI Institutional Buying and Selling by Quarter Biofrontera Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/14/2025Rosalind Advisors Inc.811,918$885K0.4%+63.9%10.476% 2/13/2025Scotia Capital Inc.25,000$27K0.0%-50.0%0.323% 2/12/2025AIGH Capital Management LLC811,097$884K0.3%+61.8%10.466% 2/11/2025Virtu Financial LLC44,106$48K0.0%N/A0.569% 2/11/2025Rosalind Advisors Inc.811,918$885K0.5%+63.9%10.476% 4/25/2024Rosalind Advisors Inc.504,261$777K0.7%N/A9.907% 2/10/2023Bard Associates Inc.198,200$182K0.1%-21.7%0.742% 8/11/2022Bard Associates Inc.259,275$482K0.2%+5.4%1.368% 5/11/2022Bard Associates Inc.246,075$819K0.3%-28.3%1.439% 2/10/2022Qube Research & Technologies Ltd13,700$103K0.0%N/A0.080% (Data available from 1/1/2016 forward) BFRI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BFRI shares? During the previous two years, the following institutional investors and hedge funds held shares of Biofrontera shares: Rosalind Advisors Inc. ($885K), AIGH Capital Management LLC ($884K), and Virtu Financial LLC ($48K), Scotia Capital Inc. ($27K).Learn more on BFRI's institutional investors. What percentage of Biofrontera stock is owned by institutional investors? 10.08% of Biofrontera stock is owned by institutional investors. Learn more on BFRI's institutional investor holdings. Which institutional investors have been buying Biofrontera stock? The following institutional investors have purchased Biofrontera stock in the last 24 months: Rosalind Advisors Inc. ($1.14M), AIGH Capital Management LLC ($309.66K), and Virtu Financial LLC ($44.11K). How much institutional buying is happening at Biofrontera? Institutional investors have bought a total of 1,490,886 shares in the last 24 months. This purchase volume represents approximately $1.85M in transactions. Which Biofrontera major shareholders have been selling company stock? The following institutional investors have sold Biofrontera stock in the last 24 months: Scotia Capital Inc. ($25K). How much institutional selling is happening at Biofrontera? Institutional investors have sold a total of 25,000 shares in the last 24 months. This volume of shares sold represents approximately $27.25K in transactions. Related Companies VYNE Institutional Ownership GBIO Institutional Ownership SCLX Institutional Ownership TPST Institutional Ownership DARE Institutional Ownership CLNN Institutional Ownership LEXX Institutional Ownership CASI Institutional Ownership GELS Institutional Ownership CARA Institutional Ownership This page (NASDAQ:BFRI) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biofrontera Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biofrontera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.